AUSTIN,
Texas, June 7, 2022 /PRNewswire/ -- Oracle
Corporation (NYSE: ORCL) announced that a majority of the
outstanding shares (the "Shares") of Cerner Corporation (Nasdaq:
CERN) were validly tendered, and the other conditions to the tender
offer have been satisfied or waived. The deal will
close on June 8, 2022. American
Stock Transfer & Trust Company LLC, the depositary for the
tender offer, has indicated that as of 12:00 midnight,
Eastern time, at the end of the day on June
6, 2022, approximately 204,280,589 Shares,
or 69.2% of the total Shares, have been validly tendered.
Larry Ellison, Oracle's Chairman
of the Board and Chief Technology Officer, will outline Oracle's
strategy to redefine the future of healthcare at a virtual
event on June 9, 2022, at
3:00 p.m. CT. Register for the
event.
About Oracle
Oracle offers integrated suites of
applications plus secure, autonomous infrastructure in the Oracle
Cloud. For more information about Oracle (NYSE: ORCL), please
visit us at oracle.com.
Trademarks
Oracle, Java, and MySQL are registered
trademarks of Oracle Corporation.
Cautionary Statement Regarding Forward-Looking
Statements
This document may contain certain forward-looking statements
about Oracle and Cerner, including statements that involve risks
and uncertainties concerning Oracle's proposed acquisition of
Cerner, anticipated customer benefits and general business outlook.
When used in this document, the words "can", "will", "expect",
"opportunity", "promises", "goal" and similar expressions and any
other statements that are not historical facts are intended to
identify those assertions as forward-looking statements. Any such
statement may be influenced by a variety of factors, many of which
are beyond the control of Oracle or Cerner, that could cause actual
outcomes and results to be materially different from those
projected, described, expressed or implied in this document due to
a number of risks and uncertainties. Potential risks and
uncertainties include, among others, the possibilities that the
transaction will not close or that the closing may be delayed, that
the anticipated synergies may not be achieved after closing, and
that the combined operations may not be successfully integrated in
a timely manner, if at all; general economic conditions in regions
in which either company does business; the
impact of the COVID-19 pandemic on how
Oracle, Cerner and their respective customers are operating their
businesses and the duration and extent to which the pandemic will
impact Oracle's or Cerner's future results of operations; and the
possibility that Oracle or Cerner may be adversely affected by
other economic, business, and/or competitive factors. Accordingly,
no assurances can be given that any of the events anticipated by
the forward-looking statements will transpire or occur, or if any
of them do so, what impact they will have on the results of
operations or financial condition of Oracle or Cerner.
In addition, please refer to the documents that Oracle and
Cerner, respectively, file with the Securities and Exchange
Commission
on Forms 10-K, 10-Q and 8-K. These
filings identify and address other important factors that could
cause Oracle's and Cerner's respective operational and other
results to differ materially from those contained in the
forward-looking statements set forth in this document. You are
cautioned to not place undue reliance on forward-looking
statements, which speak only as of the date of this document.
Except as required by law, neither Oracle nor Cerner is under any
duty to update any of the information in this document.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/oracle-completes-acquisition-of-cerner-301562766.html
SOURCE Oracle